Latest News

In recent days, Hut 8’s majority-owned subsidiary American Bitcoin Corp. experienced extreme volatility after previously locked-up shares became tradable and early investors started realizing profits, even as Bitcoin prices were strong. This turbulence has spilled over to Hut 8, raising fresh questions about how its American Bitcoin exposure affects investor confidence, corporate governance, and the resilience of its broader energy and digital infrastructure platform. We’ll now examine how...

Surgery Partners (SGRY) is back in focus after cutting its full year revenue and adjusted EBITDA outlook, a move tied to delayed capital deployment, divestiture related earnings losses, and a sharp 25% stock drop. See our latest analysis for Surgery Partners. The guidance cut and legal overhang help explain why the 30 day share price return sits at around negative 21 percent and the one year total shareholder return is down roughly 21 percent, signaling momentum that is clearly fading rather...

In recent days, analysts have become increasingly optimistic about Phreesia ahead of its October 2025-quarter earnings report, expecting year-over-year improvements in both earnings and revenue and highlighting a positive Earnings ESP alongside a consistent record of outperforming estimates. This growing optimism is underscored by multiple firms reaffirming positive ratings and lifting earnings forecasts, suggesting that expectations around Phreesia’s ability to extend its track record of...

Norges Bank recently invested about US$1.04 billion in Coinbase, coinciding with Q3 2025 results showing US$1.9 billion in revenue and a profit margin near 45%, while the company also faced a €21.5 million anti-money laundering fine in Ireland and pursued new CFTC-related regulatory proposals. At the same time, a powerful Bitcoin rally, mixed analyst opinions, insider share sales, and anticipation for Coinbase’s December 17 product reveal have collectively highlighted how tightly the...

In early December 2025, Pacira BioSciences reported 12‑month results from a 30‑patient randomized pilot study showing its iovera° cryoneurolysis treatment produced lower pain scores, better function, and fewer follow‑on spine injections than radiofrequency ablation for chronic low back pain, with no treatment‑related adverse events, alongside FDA clearance of a deeper‑reaching lumbar SmartTip device. This combination of positive clinical data and new device clearance adds weight to Pacira’s...

Braze (BRZE) just expanded its AI footprint by listing BrazeAI Decisioning Studio on Google Cloud Marketplace, giving enterprises a cleaner way to deploy its 1:1 personalization engine directly inside existing Google Cloud setups. See our latest analysis for Braze. The timing of this move is important, coming after a tough stretch where the share price return is down 31.16 percent year to date despite a modest 6.37 percent 1 month share price return, suggesting sentiment could be stabilizing...

DENTSPLY SIRONA (XRAY) just shook up its finance leadership by naming veteran executive Michael Pomeroy as interim CFO while it continues searching for a permanent hire, a move investors tend to watch closely. See our latest analysis for DENTSPLY SIRONA. The leadership shake up comes at a tough time, with a steep year to date share price return decline alongside a three year total shareholder return that signals momentum has been fading rather than building. If this kind of transition has you...

Inspur Digital Enterprise Technology Limited has completed a follow-on equity offering of HK$493,728,200, issuing 67,634,000 new ordinary shares at HK$7.30 per share with a HK$0.0511 discount per share via a subsequent direct listing. This capital raise expands the company’s funding flexibility while modestly increasing the free float, factors that can reshape how investors view its balance between growth ambitions and ownership dilution. We’ll now examine how this follow-on equity offering,...

BioMarin Pharmaceutical (BMRN) just posted its sixth straight quarter of beating Wall Street expectations, with Q2 earnings up roughly 124% year over year after its 2024 restructuring started lifting margins. See our latest analysis for BioMarin Pharmaceutical. Yet despite that earnings momentum, BioMarin’s 2025 year to date share price return is about minus 19 percent and its 1 year total shareholder return is similarly weak. This suggests sentiment has lagged improving fundamentals and...

Duke Energy (DUK) just spotlighted its community focus with nearly $275,000 in surprise microgrants to South Carolina hunger relief groups, part of a broader $600,000 campaign, and investors are asking what this means for the stock. See our latest analysis for Duke Energy. Despite the charitable spotlight, Duke Energy’s recent share price return has eased back, with the stock down over the past month but still posting a positive year to date gain. Multi year total shareholder returns suggest...

Oscar Health (OSCR) just caught traders attention after a wave of bullish options activity and a fresh analyst upgrade, which has put its structural strengths and long term growth story back in focus. See our latest analysis for Oscar Health. Those bullish options bets and the upgrade are landing just as Oscar’s 2025 year to date share price return of 26.79% builds on a massive three year total shareholder return of 527.01%. This suggests momentum is pausing rather than breaking. If Oscar’s...

China Gas Holdings (SEHK:384) just posted weaker half year earnings, with both sales and net income down from a year ago. This puts the recent share price gains into sharper context for investors. See our latest analysis for China Gas Holdings. Even with that earnings setback, the share price has climbed to HK$8.39 and delivered a robust year to date share price return of 27.12%. The 1 year total shareholder return of 41.41% suggests momentum has been rebuilding as investors reassess the risk...

With a price-to-earnings (or "P/E") ratio of 9.3x Mercedes-Benz Group AG ( ETR:MBG ) may be sending bullish signals at...

As European markets experience a positive upswing, with the pan-European STOXX Europe 600 Index closing 2.35% higher, small-cap stocks are drawing increased attention from investors looking to capitalize on potential growth opportunities. In this environment of relatively subdued inflation and rising major stock indexes across Europe, identifying small-cap companies with strong fundamentals and notable insider activity can be particularly appealing for those seeking value in the market.

Victrex plc ( LON:VCT ) will pay a dividend of £0.4614 on the 27th of February. Based on this payment, the dividend...

As European markets continue to show resilience, with major indices like the STOXX Europe 600 and Germany’s DAX posting notable gains, investors are keenly observing economic indicators such as inflation trends that suggest stability around the ECB's target. In this environment, identifying stocks that may be undervalued can offer potential opportunities for growth, especially when these companies demonstrate strong fundamentals and a capacity to thrive amid evolving market conditions.

Trustpilot Group plc ( LON:TRST ) shareholders that were waiting for something to happen have been dealt a blow with a...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Smiths Group fair value estimate is UK£25.25 Smiths Group's...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

As European markets continue to show resilience, with the pan-European STOXX Europe 600 Index closing 2.35% higher and major single-country indexes also rising, investors are paying close attention to growth opportunities within the region. In this context, companies with high insider ownership often attract interest as they can indicate strong confidence from those who know the business best, potentially aligning management's interests with shareholders'.

The recent 17% drop in Panther Metals PLC's ( LON:PALM ) stock could come as a blow to insiders who purchased UK£65.7k...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

As European markets show resilience with the pan-European STOXX Europe 600 Index closing 2.35% higher, investors are keenly observing opportunities within smaller-cap stocks. Penny stocks, though an older term, remain relevant for those seeking growth potential in emerging companies that may offer a blend of value and opportunity often overlooked by larger firms. This article will explore several such penny stocks that stand out for their financial strength and potential long-term prospects.

The Topps Tiles Plc ( LON:TPT ) share price has done very well over the last month, posting an excellent gain of 27...